IMP
Process View
regulation of mrna catabolic process
Any process that modulates the rate, frequency, or extent of a mRNA catabolic process, the chemical reactions and pathways resulting in the breakdown of RNA, ribonucleic acid, one of the two main type of nucleic acid, consisting of a long, unbranched macromolecule formed from ribonucleotides joined in 3',5'-phosphodiester linkage.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of mrna catabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| Ddx6 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 | 0.839 | ||
| Eif2c2 | eukaryotic translation initiation factor 2C, 2 | 0.766 | ||
| Neurl1a | neuralized homolog 1A (Drosophila) | 0.463 | ||
| Fos | FBJ osteosarcoma oncogene | 0.335 | ||
| Dusp1 | dual specificity phosphatase 1 | 0.277 | ||
| Junb | Jun-B oncogene | 0.262 | ||
| Zfp36 | zinc finger protein 36 | 0.147 | ||
| Egr1 | early growth response 1 | 0.125 | ||
| Tnrc6b | trinucleotide repeat containing 6b | 0.103 | ||
| Jun | Jun oncogene | 0.096 | ||
| Ldb3 | LIM domain binding 3 | 0.094 | ||
| Pum1 | pumilio 1 (Drosophila) | 0.089 | ||
| Hsp90ab1 | heat shock protein 90 alpha (cytosolic), class B member 1 | 0.087 | ||
| Bcl2 | B-cell leukemia/lymphoma 2 | 0.080 | ||
| Btg1 | B-cell translocation gene 1, anti-proliferative | 0.080 | ||
| Trim32 | tripartite motif-containing 32 | 0.074 | ||
| Akt2 | thymoma viral proto-oncogene 2 | 0.057 | Yeast | |
| Klf6 | Kruppel-like factor 6 | 0.053 | ||
| Nfkbiz | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.050 | ||
| Akt1 | thymoma viral proto-oncogene 1 | 0.047 | Yeast | |
| Nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 0.046 | ||
| Mafk | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) | 0.038 | ||
| Gsk3b | glycogen synthase kinase 3 beta | 0.035 | ||
| Nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.035 | ||
| Btg2 | B-cell translocation gene 2, anti-proliferative | 0.032 | Human | |
| Irs2 | insulin receptor substrate 2 | 0.030 | ||
| Mcl1 | myeloid cell leukemia sequence 1 | 0.028 | ||
| Mll3 | myeloid/lymphoid or mixed-lineage leukemia 3 | 0.026 | ||
| Prkce | protein kinase C, epsilon | 0.025 | ||
| Brd4 | bromodomain containing 4 | 0.024 | ||
| Pard3 | par-3 (partitioning defective 3) homolog (C. elegans) | 0.024 | ||
| Ier2 | immediate early response 2 | 0.024 | ||
| Csrnp1 | cysteine-serine-rich nuclear protein 1 | 0.022 | ||
| Bptf | bromodomain PHD finger transcription factor | 0.022 | ||
| Tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 0.021 | ||
| Ptpn22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.018 | ||
| Sp1 | trans-acting transcription factor 1 | 0.018 | ||
| Ankhd1 | ankyrin repeat and KH domain containing 1 | 0.017 | ||
| Klf7 | Kruppel-like factor 7 (ubiquitous) | 0.017 | ||
| Cd28 | CD28 antigen | 0.016 | ||
| Wnk1 | WNK lysine deficient protein kinase 1 | 0.016 | ||
| Pabpc1 | poly(A) binding protein, cytoplasmic 1 | 0.016 | ||
| Dhx36 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | 0.016 | ||
| Ppp1r15a | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.015 | ||
| Igf1r | insulin-like growth factor I receptor | 0.014 | ||
| Atf3 | activating transcription factor 3 | 0.013 | ||
| Tnfrsf13b | tumor necrosis factor receptor superfamily, member 13b | 0.012 | ||
| Foxo1 | forkhead box O1 | 0.012 | ||
| Actn2 | actinin alpha 2 | 0.011 | ||
| Mael | maelstrom homolog (Drosophila) | 0.011 | ||
| Ncoa3 | nuclear receptor coactivator 3 | 0.011 | ||
| Midn | midnolin | 0.011 | ||
| Vhl | von Hippel-Lindau tumor suppressor | 0.010 | ||
| Rhob | ras homolog gene family, member B | 0.010 | ||
| Csnk2a1 | casein kinase 2, alpha 1 polypeptide | 0.010 |